NIAOULI CT 1,8-cinéole
Food supplement declared in France, declaration No 2022-11-466, decision dated 10 November 2022
NIAOULI CT 1,8-cinéole (Panacea Pharma) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Melaleuca quinquenervia 100 mg per day. None of the rules we check flags an issue with its declared composition.
- Brand
- Panacea Pharma
- Food business operator placing the product on the market
- PANACEA PHARMA LTEE
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Dropper
- Daily dose
- 3 gouttes par jour
- Directions for use
- Prendre 1 goutte 3 fois par jour sur un comprimé neutre
- Not recommended (according to the manufacturer)
- Breastfeeding women, Children (under 12), Young children (aged 1 to 3), Pregnant women, Infants (under 1 year), Taking medication, Children (under 6), Children (under 10)
Declaration 310161, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Melaleuca quinquenervia (Cav.) S.T. Blake | Essence (feuille) | Distillation | 100 mg |
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Complément alimentaire, ne peut se substituer à une alimentation variée et équilibrée. À consommer dans le cadre d’un mode de vie sain. Tenir hors de portée des enfants. Ne pas dépasser la dose journalière recommandée. Déconseillé aux enfants de moins de 12 ans, femmes enceintes ou allaitantes.Ne pas utiliser de manière prolongée (maximum 14 jours). Consultez un professionnel de santé avant utilisation surtout en cas de traitement antiépileptique ou d’antécédent de convulsion. Ne jamais prendre pure par voie orale sans support. Éviter tout contact avec les yeux et les muqueuses.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- NIAOULI CT 1,8-cinéole Panacea Pharma, declared in 2022, earlier declaration, replaced by the 2022 declaration : same declared composition
Brand : Panacea Pharma
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “NIAOULI CT 1,8-cinéole (Panacea Pharma): composition and regulation”, https://compoatlas.com/en/supplements/products/310161-niaouli-ct-1-8-cineole, updated 15 November 2026.